Cancer: the evolved consequence of a destabilized genome

被引:50
作者
Anderson, GR
Stoler, DL
Brenner, BM
机构
[1] New York State Dept Hlth, Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA
[2] New York State Dept Hlth, Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA
[3] New York State Dept Hlth, Roswell Pk Canc Inst, Dept Expt Pathol, Buffalo, NY 14263 USA
关键词
D O I
10.1002/bies.1149
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The genome is a stable repository of vastly intricate genetic information developed over eons of evolution; this information is replicated at the highest fidelity and expressed within each cell at the highest selectivity. Non-leukemia cancers break this standard; the intricate genetic information qualitatively and progressively deteriorates, resulting in a somatic Darwinian free-for-all. In a process lasting several years, a genomically heterogeneous population replicates from a single cell that originally lost the ability to preserve its genomic integrity. Cells selected for their abilities to proliferate and spread, while evading host defenses, inexorably expand their numbers. The clinical consequences of this become severe, as the genomically diverse cell population that evolves contains members that can evade most therapeutic approaches aimed at "the tumor cell". BioEssays 23:1037-1046, 2001. (C) 2001 John Wiley & Sons, Inc.
引用
收藏
页码:1037 / 1046
页数:10
相关论文
共 56 条
  • [1] Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement
    Abdel-Rahman, WM
    Katsura, K
    Rens, W
    Gorman, PA
    Sheer, D
    Bicknell, D
    Bodmer, WF
    Arends, MJ
    Wyllie, AH
    Edwards, PAW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) : 2538 - 2543
  • [2] Evolution of neoplastic cell lineages in Barrett oesophagus
    Barrett, MT
    Sanchez, CA
    Prevo, LJ
    Wong, DJ
    Galipeau, PC
    Paulson, TG
    Rabinovitch, PS
    Reid, BJ
    [J]. NATURE GENETICS, 1999, 22 (01) : 106 - 109
  • [3] Clinical trials of Herceptin® (trastuzumab)
    Baselga, J
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 : S18 - S24
  • [4] Basik M, 1997, GENE CHROMOSOME CANC, V18, P19, DOI 10.1002/(SICI)1098-2264(199701)18:1<19::AID-GCC3>3.3.CO
  • [5] 2-2
  • [6] Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
    Baylin, SB
    Esteller, M
    Rountree, MR
    Bachman, KE
    Schuebel, K
    Herman, JG
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (07) : 687 - 692
  • [7] Bishop AJR, 2000, CANCER RES, V60, P395
  • [8] Boland CR, 1998, CANCER RES, V58, P5248
  • [9] Don't stop for repairs in a war zone: Darwinian evolution unites genes and environment in cancer development
    Breivik, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) : 5379 - 5381
  • [10] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
    Druker, BJ
    Talpaz, M
    Resta, DJ
    Peng, B
    Buchdunger, E
    Ford, JM
    Lydon, NB
    Kantarjian, H
    Capdeville, R
    Ohno-Jones, S
    Sawyers, CL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1031 - 1037